Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

May 28, 2007

Couldn't agree more

Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Kenneth Edelson 
Owner, Kenneth Edelson, MD
Implications: Keep Hydroquinones Around!

Analysis: The potential FDA ban of OTC hydroquinones is totally unnecessary! The OTC concentrations are low and have not caused any significant side effects in the scores of years they have been around. In addition, the stronger prescription strength formulas including combinations with steroids, retinoic acids, alpha hydroxy acids or sunscreens have not caused any significant issues either. The rare cases of ochronosis or rebound hyperpigmentation are just that...extremely rare.
Of course the only ones to benefit from banning the OTC hydroquinones are the drug companies who make the prescription strength formulas.

Other Analyses of the Same Source Article:
FDA ban on Hydroquinones
May 29, 2007, Author: GLG Expert Contributor
FDA Hydroquinone ban may be premature
May 24, 2007, Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics